Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

61f266dd-2363-417d-b436-30ae129762cb - samples

ABSTRACT: Whole genome sequencing data of 6 high-grade serous carcinoma (HGSC) patients (11 samples) sequenced with MGISEQ-2000

PROVIDER: EGAD00001011353 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

28c859a0-73c1-4b84-a18a-8aedb673f714 - samples

Project description:Whole genome sequencing data of 21 high-grade serous carcinoma (HGSC) patients (59 samples) sequenced with MGISEQ-2000.

| EGAD00001011086 | EGA

673391a6-0ad1-4e26-a3ad-0c6a8e2821b8 - samples

Project description:Whole genome sequencing data of 26 high-grade serous carcinoma (HGSC) patients (87 samples) sequenced with MGISEQ-2000 and HiSeq X Ten.

| EGAD00001011304 | EGA

7548f492-dc40-4c94-bf1c-c3c4465bc6e0 - samples

Project description:Sequencing data of 10 high-grade serous carcinoma (HGSC) patients (58 samples including blood derived normal samples as germline controls, fresh frozen tissue samples as tissue controls and organoids) sequenced with HiSeq X Ten / BGISEQ-500 / MGISEQ-2000.

| EGAD00001010019 | EGA

Identification of Prognostic Biomarkers of Ovarian High Grade Serous Carcinoma through Spatial Transcriptome Analysis and Multispectral imaging

Project description:The identification of reliable predictive biomarkers is crucial for assessing optimal therapeutic responsiveness in high grade serous ovarian carcinoma (HGSC). The immune profile of the tumor microenvironment (TME) influenced the prognosis of HGSC patients. Using spatial transcriptome analysis, We investigated the characteristics of the tumor microenvironment associated with treatment response and identified multiple biomarkers associated with treatment benefit in HGSC patients.

2025-05-07 | GSE279969 | GEO

Targeted mass spectrometry of longitudinal patient sera reveals LTBP1 as a potential surveillance biomarker for high-grade serous ovarian carcinoma

Project description:Targeted proteomics dataset (PRM) investigating four potential biomarker candidates of high-grade serous ovarian carcinoma (FGL2, LGALS3BP, LTBP1, TIMP1) and the established biomarker CA125 in 212 serum samples taken from 34 HGSC patients during disease progression.

| MSV000092904 | MassIVE

ATAC-seq analysis for OVSAHO cells with upregulated SMARCA2 and downregulated SMARCA4 expression

Project description:The goal of this study is to explore the underlying mechanism which contributes to chemoresistance in high-grade serous carcinoma (HGSC) with low SMARCA4 and high SMARCA2 expression.

2023-02-07 | GSE212885 | GEO

RNA-seq analysis for OVSAHO cells with upregulated SMARCA2 and downregulated SMARCA4 expression

2023-02-07 | GSE212886 | GEO

Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort [OncoScan_CNV]

Project description:The JGOG3025 study was conducted by the Japanese Gynecologic Oncology Group (JGOG) on 710 patients with epithelial ovarian cancer (NCT03159572). In the JGOG3025-TR2 study, fresh frozen tumor tissues from 274 and 15 cases diagnosed as stage II or higher high-grade serous carcinoma (HGSC) or high-grade endometrioid carcinoma (HGEC) in the central pathological review were submitted to SNP array, total RNA-sequencing, and DNA methylation array analyses.

2024-08-31 | GSE263437 | GEO